APLP2 and familial pancreatic carcinoma: Our results with the novel KPC Aplp2−/−, KPC Aplp2−/+, and KPC Aplp2+/+ mouse strains will promote the pursuit of additional studies to validate APLP2 as a target for utilization in new efforts to treat pancreatic cancer.